首页> 美国卫生研究院文献>other >Incompatibilities of lornoxicam with 4 antiemetic medications in polyolefin bags during simulated intravenous administration
【2h】

Incompatibilities of lornoxicam with 4 antiemetic medications in polyolefin bags during simulated intravenous administration

机译:模拟静脉内给药期间氯诺昔康与4种止吐药在聚烯烃袋中的不相容性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The administration of drugs by patient-controlled analgesia (PCA) is routinely practiced for the management of postoperative pain. It is common for 2 or more drugs to be combined in PCA solutions. The combination of analgesics and antiemetic agents is frequently required. Unfortunately, the compatibility and stability of lornoxicam and antiemetic agents, such as droperidol, ondansetrone, granisetron, and tropisetron, has not been determined. The aim of this study was to evaluate the compatibility and stability of solutions containing lornoxicam with the 4 antiemetic agents in combination for PCA administration.In our study, test samples were prepared in triplicate by adding 40 mg lornoxicam and 5 mg droperidol, 8 mg ondansetron, 6 mg granisetron, or 5 mg tropisetron to 100-mL polyolefin bags of sodium chloride 0.9% and stored at 25 °C. The analgesic mixture samples were visually inspected for precipitation, cloudiness, and discoloration at each sampling interval. Drug concentrations were determined using high-performance liquid chromatographic (HPLC) analysis.No loss of lornoxicam occurred with any of the 4 antiemetic agents tested for up to 48 hours. However, the contents of droperidol, ondansetron, granisetron, and tropisetron were significant loss >48 hours. After storage of 4.0 to 48.0 hours, the presence of a slight precipitate was observed in all the injection combinations.The results indicate that combinations of lornoxicam with droperidol, ondansetrone, granisetron, or tropisetron in infusion solution during simulated intravenous PCA administration were incompatibility when stored protected from light at 25 °C.
机译:通常采用患者自控镇痛(PCA)来管理术后疼痛。通常在PCA解决方案中结合两种或两种以上药物。经常需要止痛药和止吐药的组合。不幸的是,尚未确定氯诺昔康和止吐剂,例如氟哌啶,恩丹西酮,格拉司琼和托吡司琼的相容性和稳定性。这项研究的目的是评估含氯诺昔康与4种止吐药联合用于PCA的溶液的相容性和稳定性。在我们的研究中,通过一式三份添加40μmg氯诺昔康和5μmg氟哌啶,8μmg的恩丹西酮制备测试样品。 ,6 µg格拉司琼或5 µmg托洛司琼加入100 mL的0.9%氯化钠聚烯烃袋中,并在25°C下储存。在每个取样间隔,目视检查止痛混合物样品的沉淀,浑浊和变色。使用高效液相色谱(HPLC)分析确定药物浓度。在长达48小时的测试中,使用4种止吐剂中的任何一种均未出现氯诺昔康的损失。但是,氟哌多尔,恩丹西酮,格拉司琼和托吡司琼的含量在> 48小时时明显损失。贮存4.0至48.0小时后,在所有注射组合中均观察到少量沉淀。结果表明,在模拟静脉PCA给药过程中,氯诺昔康与氟哌啶,恩丹西酮,格拉司琼或托吡司琼的组合在输注溶液中不相容。避开25°C的光照。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号